Biotech layoffs continue as Ambrx cuts staff and part of its pipeline to extend its cash

San Diego-based biotech Ambrx announced that it is reorganizing its pipeline and cutting around 15% of its staff to extend its cash resources. According to the company’s most recent annual report to the SEC, filed last December, Ambrx had around 81 employees.